Cargando…
Apicoplast ribosomal protein S10-V127M enhances artemisinin resistance of a Kelch13 transgenic Plasmodium falciparum
BACKGROUND: The resistance of Plasmodium falciparum to artemisinin-based (ART) drugs, the front-line drug family used in artemisinin-based combination therapy (ACT) for treatment of malaria, is of great concern. Mutations in the kelch13 (k13) gene (for example, those resulting in the Cys580Tyr [C580...
Autores principales: | Kampoun, Tanyaluck, Srichairatanakool, Somdet, Prommana, Parichat, Shaw, Philip J., Green, Judith L., Knuepfer, Ellen, Holder, Anthony A., Uthaipibull, Chairat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615251/ https://www.ncbi.nlm.nih.gov/pubmed/36303209 http://dx.doi.org/10.1186/s12936-022-04330-3 |
Ejemplares similares
-
Deletion of Plasmodium falciparum ubc13 increases parasite sensitivity to the mutagen, methyl methanesulfonate and dihydroartemisinin
por: Maneekesorn, Supawadee, et al.
Publicado: (2021) -
Antagonistic antimalarial properties of a methoxyamino chalcone derivative and 3-hydroxypyridinones in combination with dihydroartemisinin against Plasmodium falciparum
por: Kampoun, Tanyaluck, et al.
Publicado: (2023) -
Transgenic Plasmodium parasites stably expressing Plasmodium vivax dihydrofolate reductase-thymidylate synthase as in vitro and in vivo models for antifolate screening
por: Somsak, Voravuth, et al.
Publicado: (2011) -
Monitoring drug resistance in Plasmodium falciparum clinical isolates collected from Northern Thailand
por: Uthaipibull, Chairat, et al.
Publicado: (2014) -
Inducible Knockdown of Plasmodium Gene Expression Using the glmS Ribozyme
por: Prommana, Parichat, et al.
Publicado: (2013)